Eptifibatide - NDC Database (Page 2)
44 records found
Page:
62147-0601 Jan 01, 2020
Eptifibatide .75 mg/ml Intravenous Injection, Solution by Usv Private Limited
Eptifibatide .75 mg/ml Intravenous Injection, Solution by Usv Private Limited
63739-911 Mar 20, 2020
Eptifibatide 20 mg/10ml Intravenous Injection, Solution by Mckesson Corporation Dba Sky Packaging
Eptifibatide 20 mg/10ml Intravenous Injection, Solution by Mckesson Corporation Dba Sky Packaging
63739-923 Mar 20, 2020
Eptifibatide 200 mg/100ml Intravenous Injection, Solution by Mckesson Corporation Dba Sky Packaging
Eptifibatide 200 mg/100ml Intravenous Injection, Solution by Mckesson Corporation Dba Sky Packaging
63739-970 Mar 20, 2020
Eptifibatide 75 mg/100ml Intravenous Injection, Solution by Mckesson Corporation Dba Sky Packaging
Eptifibatide 75 mg/100ml Intravenous Injection, Solution by Mckesson Corporation Dba Sky Packaging
67457-629 Oct 01, 2018
Eptifibatide 2 mg/ml Intravenous Injection, Solution by Mylan Institutional LLC
Eptifibatide 2 mg/ml Intravenous Injection, Solution by Mylan Institutional LLC
67457-630 Oct 01, 2018
Eptifibatide 2 mg/ml Intravenous Injection, Solution by Mylan Institutional LLC
Eptifibatide 2 mg/ml Intravenous Injection, Solution by Mylan Institutional LLC
67457-631 Dec 13, 2018
Eptifibatide .75 mg/ml Intravenous Injection, Solution by Mylan Institutional LLC
Eptifibatide .75 mg/ml Intravenous Injection, Solution by Mylan Institutional LLC
70436-027 Jul 22, 2019
Eptifibatide .75 mg/ml Intravenous Injection by Slate Run Pharmaceuticals, LLC
Eptifibatide .75 mg/ml Intravenous Injection by Slate Run Pharmaceuticals, LLC
70436-163 Jul 22, 2019
Eptifibatide .75 mg/ml Intravenous Injection by Slate Run Pharmaceuticals, LLC
Eptifibatide .75 mg/ml Intravenous Injection by Slate Run Pharmaceuticals, LLC
70860-303 Mar 21, 2022
Eptifibatide 2 mg/ml Intravenous Injection, Solution by Athenex Pharmaceutical Division, LLC.
Eptifibatide 2 mg/ml Intravenous Injection, Solution by Athenex Pharmaceutical Division, LLC.
70860-305 Sep 30, 2022
Eptifibatide .75 mg/ml Intravenous Injection, Solution by Athenex Pharmaceutical Division, LLC.
Eptifibatide .75 mg/ml Intravenous Injection, Solution by Athenex Pharmaceutical Division, LLC.
71288-412 May 09, 2024
Eptifibatide 2 mg/ml Intravenous Injection, Solution by Meitheal Pharmaceuticals Inc.
Eptifibatide 2 mg/ml Intravenous Injection, Solution by Meitheal Pharmaceuticals Inc.
71288-413 May 09, 2024
Eptifibatide .75 mg/ml Intravenous Injection, Solution by Meitheal Pharmaceuticals Inc.
Eptifibatide .75 mg/ml Intravenous Injection, Solution by Meitheal Pharmaceuticals Inc.
72078-025 Apr 01, 2021
Eptifibatide 2 mg/ml Intravenous Injection, Solution by Mylan Institutional LLC
Eptifibatide 2 mg/ml Intravenous Injection, Solution by Mylan Institutional LLC
Page:
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.